Search the Newsreel

Alignment Healthcare boasts 32% revenue jump in Q2, lifts 2026 outlook

Alignment Healthcare reported a significant 31.6% revenue increase to $1.34 billion in Q2 2026, exceeding analyst expectations. The company attributed this strong performance to its new AI-powered stratification model, which helps predict hospitalizations and optimize care. Alignment also raised its 2026 forecast, projecting membership …

Align Technology Number of Employees 2026 | Employee Count & Headcount Data

Align Technology (NASDAQ: ALGN) had approximately 20,427 employees worldwide as of March 2026, representing an 8.2% decline since 2023. The company is actively hiring, with 829 active job postings in 2026, a 21.7% increase from the previous year. While overall employee sentiment is neutral …

Crealights Locks In 2027 DSP Chip Supply to Bolster Optical Module Production

Align Technology (ALGN) Stock Slides As Scanner Reset Clouds Aligner Strength

Align Technology's stock fell 3.7% following its Q2 2026 earnings report, despite a strong performance in its clear aligner segment with record case volumes and improved operating margins. The decline was largely attributed to a weaker Systems and Services business, which saw revenue decrease …

Alignment Healthcare (NASDAQ: ALHC) raises 2026 outlook after Q2 revenue jump

Alignment Healthcare (ALHC) reported strong Q2 2026 results, with total revenue increasing by 31.6% year-over-year to $1,335.6 million and health plan membership growing by 31.5% to approximately 294,100. The company surpassed its guidance across key metrics, achieving adjusted EBITDA of $68.1 million and net …

Alignment Healthcare, Inc. Quarterly Earnings Report

Alignment Healthcare, Inc. (ALHC) reported its quarterly earnings, with a net income of $36.56 million for the quarter ended June 30, 2026, and $47.98 million for the six months ended June 30, 2026. The company experienced significant growth in Health Plan membership, reaching 294,100 …

Alignment Healthcare: Q2 Earnings Snapshot

Alignment Healthcare (ALHC) reported strong second-quarter results, with earnings of $36.6 million, or 17 cents per share, surpassing Wall Street expectations of 13 cents per share. The Medicare Advantage insurer also exceeded revenue forecasts, posting $1.34 billion against an expected $1.31 billion. Despite a …

Align Technology (ALGN) Reports Record Q2 Revenue, Is The Stock Still Below Fair Value?

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. What the latest guidance and Q2 results tell you about Align Technology Align Technology …

Alignment Healthcare, Inc. (ALHC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Alignment Healthcare, Inc. (ALHC) following allegations of accounting irregularities that "artificially inflated" the company's financial results. A whistleblower complaint suggests "millions of dollars in operating expenses had been systematically misclassified as capital expenditures," leading …

Compared to Estimates, Alignment Healthcare (ALHC) Q2 Earnings: A Look at Key Metrics

For the quarter ended June 2026, Alignment Healthcare (ALHC) reported revenue of $1.34 billion, up 31.6% over the same period last year. EPS came in at $0.17, compared to $0.07 in the year-ago quarter. The reported revenue represents a surprise of +1.97% over the …

Bragar Eagel & Squire, P.C. is Investigating Alight, Inc.

Bragar Eagel & Squire, P.C. is investigating potential claims against Alight, Inc. (NYSE: ALIT) on behalf of long-term stockholders. This follows a class action complaint filed on March 16, 2026, alleging that Alight made false and misleading statements about its growth potential and financial …

Alignment Healthcare (ALHC) Beats Q2 Earnings and Revenue Estimates

Alignment Healthcare (ALHC) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.07 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Can Align Technology (ALGN) Still Be Undervalued After Its Review?

Align Technology (ALGN) appears undervalued according to a Discounted Cash Flow (DCF) analysis, suggesting a 39.7% discount to its estimated intrinsic value. However, its P/E ratio is broadly in line with industry peers, indicating a mixed valuation picture. The company's recent strong stock recovery …

Align Technology Announces Board Changes and Strategic Review

Align Technology announced several corporate initiatives, including the appointment of three independent directors to its board and an increased share repurchase commitment, following discussions with activist investor Elliott Investment Management. These changes aim to strengthen commercial execution, enhance organizational effectiveness, and optimize resources. The …

Alignment Healthcare, Inc. (ALHC) Q2 2026 Earnings

Alignment Healthcare, Inc. (ALHC) reported its Q2 2026 earnings, missing EPS estimates by 16% with $0.17 against an estimated $0.20, despite a 48% jump in adjusted EBITDA. The company beat revenue expectations by 2%, reaching $1.34 billion, driven by a 31.5% membership surge. ALHC …

Alignment Healthcare (NASDAQ:ALHC) Beats Q2 CY2026 Sales Expectations But Stock Drops

Alignment Healthcare (NASDAQ:ALHC) Beats Q2 CY2026 Sales Expectations But Stock Drops Health insurance company Alignment Healthcare (NASDAQ:ALHC) reported Q2 CY2026 results topping the market's revenue expectations , with sales up 31.6% year on year to $1.34 billion. The company expects next quarter's revenue to …

Lowey Dannenberg, P.C. is Investigating Alignment

Lowey Dannenberg, P.C. is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential federal securities law violations. This investigation follows a whistleblower lawsuit alleging that Alignment manipulated its finances by misclassifying operating expenses as capital expenditures to inflate its adjusted EBITDA and boost its stock …

Alignment Healthcare Turns Profit As Insurer Gets Handle On Costs

Alignment Healthcare reported a significant increase in its second-quarter net income, more than doubling to $36.6 million, primarily due to lower medical costs for its Medicare Advantage members. The company's medical benefit ratio improved to 86%, marking a second consecutive quarter of decline in …

ALGN Stock Up Post Q2 Earnings and Revenue Beat, Margins Rise

Align Technology, Inc. ALGN reported second-quarter 2026 non-GAAP earnings of $2.64 per share, up 6.0% year over year. The figure beat the Zacks Consensus Estimate by 3.1%. Revenues increased 4.3% to $1.06 billion and topped the consensus mark by 0.4%. The quarterly results benefited …

Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics

Alignment Healthcare, Inc. (NASDAQ: ALHC) announced strong second-quarter 2026 financial results, exceeding guidance across all key metrics. The company reported $1.3 billion in total revenue, a 31.6% year-over-year increase, and grew Medicare Advantage membership by 31.5% to approximately 294,100 members. Consequently, Alignment Healthcare raised …

PACS or ALHC: Which Is the Better Value Stock Right Now?

Investors interested in Medical Services stocks are likely familiar with PACS Group, Inc. (PACS) and Alignment Healthcare (ALHC). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. We have found that the …

ALGN Q2 Earnings Call Highlights Digital Growth Push

Align Technology (ALGN) highlighted strong Invisalign growth and expanding digital workflows in its Q2 2026 earnings call, despite near-term pressures from scanner pricing changes. The company reported record clear aligner volumes and strategic investments to drive adoption, while also focusing on improving operating margins …

Bronstein, Gewirtz & Grossman, LLC Is Investigating Alignment Healthcare, Inc. (ALHC) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Alignment Healthcare, Inc. (ALHC) following allegations of accounting irregularities that artificially inflated financial results. A whistleblower complaint suggests "millions of dollars in operating expenses had been systematically misclassified as capital expenditures," leading to a …

Aligos Therapeutics to Announce 2nd Quarter 2026 Financial Results on August 6, 2026

Aligos Therapeutics (NASDAQ: ALGS), a clinical-stage biotechnology company focusing on liver and viral diseases, announced it will release its second quarter 2026 financial results on Thursday, August 6, 2026, before U.S. financial markets open. The company's stock rose 5.4% following this announcement, consistent with …

Why is Align Technology stock sliding today?

Align Technology's stock is sliding due to a lower-than-expected revenue outlook for Q3 2026, overshadowing otherwise solid Q2 results. The company also faces challenges in its Systems and Services revenue, a significant UK VAT liability, and upcoming restructuring costs, although it did increase its …

Needham reiterates Hold on Align Technology stock after Q2 results

Needham maintained its Hold rating on Align Technology (NASDAQ:ALGN) after the company’s Q2 2026 results. While Clear Aligner performance was strong, it was offset by weaker Systems revenue due to negative mix shifts, which is expected to limit upside in the near term. The …

Align Technology Plans to Add Board Members After Talks With Elliott

Align Technology (ALGN) is reportedly planning to add new independent board members following discussions with activist investor Elliott Investment Management. While the number of new directors and specific individuals were not disclosed, reports indicate that Align is considering a range of candidates, including those …

Aligos Therapeutics Inc (ALGS) Valuation: PE, PB & Fair Value Analysis

Aligos Therapeutics Inc (ALGS) has a current valuation score of 8.75, placing it 62nd out of 385 companies in the Biotechnology & Medical Research industry. Its P/E ratio is -0.43, indicating it is -31.58% below its recent high and significantly above its recent low. …

Alignment Healthcare LLC earnings beat by $0.04, revenue fell short of estimates

Aligos Therapeutics to report results before markets open Aug. 6

ALHC|Alignment Healthcare Inc|Price:18.290|Chg%:-0.140

Alignment Healthcare Inc (ALHC) exhibits strong fundamentals and high growth potential, despite recent weak stock market performance. The company's valuation is considered fair, ranking 5th in its industry, with high institutional ownership and multiple analyst "Buy" ratings. Its stock price is currently trading sideways, …

Aligos Therapeutics Inc (ALGS) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Aligos Therapeutics Inc (ALGS), focusing on current price momentum, support and resistance levels, and various technical indicators and moving averages. The stock currently has a price momentum score of 5.70, trading between a resistance of 6.23 and …

Align Technology Inc (ALGN) (Q2 2026) Earnings Call Highlights: Record Revenue and Clear ...

This article first appeared on GuruFocus. Revenue: Record Q2 2026 revenue of $1.06 billion, up 4.3% year-over-year. Clear Aligner Revenue: $870.9 million, up 8.2% year-over-year. Clear Aligner Volume: Record 692,000 cases, up 7.4% year-over-year. Clear Aligner ASP: $1,260 per case, up 0.8% year-over-year. Systems …

Align outlines 2027 operating margin +100 bps target while planning $400M-$500M 2026 buybacks

Earnings Call Insights: Align Technology (ALGN) Q2 2026 MANAGEMENT VIEW * "We delivered a solid second quarter with record revenues of $1.06 billion, up 4.3% year-over-year, driven by record Clear Aligner volumes of 692,000 cases and 8.2% Clear Aligner revenue growth," said (President, CEO …

Align Technology Hosts 2026 Invisalign® Ortho Summit, Showcasing a “Beyond Possible” Vision for Connected Digital Orthodontics

Align Technology recently hosted its 2026 Invisalign Ortho Summit, bringing together over 500 orthodontists to explore advancements in digital orthodontic care. The event, themed "Beyond Possible," highlighted new innovations like the Invisalign Specifix System, integrated buttons, and enhanced iTero Lumina intraoral scanner features, aiming …

Align Technology (ALGN) Reports Q2 Earnings: What Key Metrics Have to Say

Align Technology (ALGN) reported $1.06 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 4.3%. EPS of $2.64 for the same period compares to $2.49 a year ago. The reported revenue represents a surprise of +0.43% over the Zacks …